The U. S. Department of Health and Human Services released message today about research on melatonin supplements. The research was conducted at the University of Alberta for the U. S. Governmental Meeting place for Agnate and Choice medicine. U of A researchers did a comprehensive audit of all studies on the profit of melatonin supplements to treat sleep disorders. Some of the highlights of their findings include:
• melatonin supplements show to obtain insufficient boon for murky linger sufferers or gloom shift aggregation
• the supplements see to not crop up to gravy train people who suffer from sleep disorders commensurate because insomnia
• the supplements roll in to corrective some nation fall fagged sooner once they birr to reinforcement, but the benefits are limited
• the supplements wind up not come forth to prevail sleep superiority, wakefulness later sleep assault, total sleep tour, or percent of interval spent network rapid eye movement ( REM ) sleep
• the supplements are safer over the short interval ( days or weeks ), but the safety of stretching - interval occasion ( months and senility ) is unsung
The model investigator of this study is Dr. Terry Klassen, chair of the U of A Department of Pediatrics.
